Close

More on KRYS

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-2.6% Growth)
- Ratings (10.0 Score)
- Holders

Upcoming Events

- Earnings (11/6/23)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Krystal Biotech (NQ:KRYS)
Delayed: 115.14 -3.63 (3.06%)
Prev. Close $118.77  
Open$118.83 
52 Wk High$ 
52 Wk Low$ 
Day High$119.11 
Day Low$114.87 
P/E N/A  
EPS$ 
Volume273,084 

Friends, Peers and Foes (?): TSVT, ORTX, XFOR, RARE, CLLS (more...)

Sep 21, 2023 09:00 AM Krystal Biotech (KRYS) Granted FDA Clearance of IND Application for KB408
Sep 21, 2023 09:00 AM Krystal Biotech Announces FDA Clearance of Investigational New Drug Application for KB408 for the Treatment of Type 1 Alpha-1 Antitrypsin Deficiency
Sep 12, 2023 06:01 PM Form 4 Krystal Biotech, Inc. For: Sep 11 Filed by: Krishnan Suma
Sep 12, 2023 06:00 PM Form 4 Krystal Biotech, Inc. For: Sep 11 Filed by: Krishnan Krish S
Sep 11, 2023 04:17 PM Form 144 Krystal Biotech, Inc. Filed by: Krishnan Krish S
Sep 11, 2023 04:17 PM Form 144 Krystal Biotech, Inc. Filed by: Krishnan Suma
Sep 7, 2023 07:00 AM Krystal Biotech to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
Sep 7, 2023 02:48 AM Berenberg Starts Krystal Biotech (KRYS) at Buy, 'Undervalued gene delivery platform for rare disease'
Sep 5, 2023 07:03 AM Krystal Biotech (KRYS) Granted FDA Orphan Drug Designation for KB408
Sep 5, 2023 07:00 AM Krystal Biotech Announces Orphan Drug Designation Granted to KB408 for the Treatment of Alpha-1 Antitrypsin Deficiency
View All Articles

Entities mentioned with KRYS

View All Entities